Intrathecal neuromedin C enhances mechanical nociception: possible involvement of NMDA receptors.
Intrathecal administration of neuromedin C (3, 10 nmol/rat) significantly decreased the nociceptive threshold of rats in the paw-pressure test. This effect was abolished by co-administration of [Leu13 psi(CH2NH)-Leu14]bombesin (10 nmol/rat), a bombesin receptor antagonist. Co-administration of 2-amino-5-phosphonovaleric acid (APV) at a dose (10 nmol/rat) which did not affect the nociceptive threshold by itself significantly inhibited the effect of neuromedin C. 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX) (10 nmol/rat) did not significantly inhibit the neuromedin C-induced hyperalgesia. These results indicate that neuromedin C could modulate mechanical nociception through bombesin receptors at the spinal level, where glutamate is involved through NMDA receptors.